➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
McKesson
McKinsey
Boehringer Ingelheim
AstraZeneca

Last Updated: February 24, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMBIEN

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Ambien

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00042146 Behavioral and Pharmacological Treatment for Insomnia Completed National Institute of Mental Health (NIMH) Phase 4 2001-12-01 This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.
NCT00042146 Behavioral and Pharmacological Treatment for Insomnia Completed Laval University Phase 4 2001-12-01 This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.
NCT00044629 Combined Behavioral/Pharmacological Therapy for Insomnia Completed National Institute of Mental Health (NIMH) Phase 2 2001-09-01 This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
NCT00044629 Combined Behavioral/Pharmacological Therapy for Insomnia Completed Duke University Phase 2 2001-09-01 This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
NCT00086281 Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients Completed Jazz Pharmaceuticals Phase 4 2003-11-01 To study the effect of Xyrem (9 g), Xyrem (9 g) plus modafinil 200 mg administered the morning prior to Xyrem, positive control (zolpidem 10 mg), and placebo on the frequency and outcome of events of sleep-disordered breathing in patients with obstructive sleep apnea syndrome (OSAS).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ambien

Condition Name

Condition Name for Ambien
Intervention Trials
Insomnia 9
Healthy 9
Sleep 4
Sleep Initiation and Maintenance Disorders 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ambien
Intervention Trials
Sleep Initiation and Maintenance Disorders 18
Depression 4
Sleep Wake Disorders 3
Parasomnias 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ambien

Trials by Country

Trials by Country for Ambien
Location Trials
United States 91
Canada 7
Germany 4
United Kingdom 4
Italy 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Ambien
Location Trials
Pennsylvania 9
California 9
New York 7
Massachusetts 6
Ohio 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ambien

Clinical Trial Phase

Clinical Trial Phase for Ambien
Clinical Trial Phase Trials
Phase 4 18
Phase 3 3
Phase 2/Phase 3 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ambien
Clinical Trial Phase Trials
Completed 32
Recruiting 5
Not yet recruiting 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ambien

Sponsor Name

Sponsor Name for Ambien
Sponsor Trials
National Institute of Mental Health (NIMH) 6
Sanofi 5
University of Pittsburgh 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ambien
Sponsor Trials
Other 36
Industry 24
NIH 13
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Moodys
Merck
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.